Festival of Biologics USA 2027

How it compares

BioProcess International is the more concentrated choice for a process-development or manufacturing team. Its cell-line, upstream, downstream, digital manufacturing and CMC themes go directly into scale-up, quality and operational performance. Festival of Biologics USA places those concerns in a wider therapeutic conversation, connecting process decisions with antibody formats, clinical development, biosimilars and access to treatment.

The sister Festival of Biologics Basel covers the same discovery-to-market chain through a European community of developers, researchers and their partners. It offers a comparable mix of antibodies, immunotherapy, cell and gene therapies and biosimilars. The US festival’s Boston setting brings that format into a region where academic research, biotech development and manufacturing partners work in close proximity.

Choose BPI when the problem sits inside the manufacturing process. Basel suits a biologics team building European scientific and commercial relationships. The US festival is useful when discovery, development and delivery need to be considered together, especially where a new therapeutic format creates questions that cross departmental boundaries.

Festival of Biologics USA suits biologics teams connecting molecular discovery with development, manufacturing and patient access.

Who exhibits

Schrodinger and Biointron point toward computational discovery and antibody research, while Vector Laboratories and BPS Bioscience bring reagents and analytical tools. Ajinomoto Bio-Pharma Services and Grand River Aseptic Manufacturing extend the discussion into development, drug substance and sterile fill and finish. The mix gives visitors a route across the biologics supply chain, from testing an early idea to choosing the partners and processes needed to produce a therapy.

This year's list is on its way. A HallBrief brief ranks every exhibitor against your goals and finds who to meet at each. Get a brief

Festival of Biologics USA 2027

The 2027 festival brings its discovery-to-market format to Boston after the previous San Diego event. The program connects antibody engineering and AI with cell-therapy manufacturing, biosimilar commercialization and patient access. Named sessions include affordability across the value chain and an AI panel backed by Cradle. The supplier line-up adds a space-manufacturing dimension through BioOrbit, alongside laboratory tools, CDMOs and sterile manufacturing specialists.

• Compare protein-engineering and antibody-immunotherapy sessions with the CMC and manufacturing discussions; the same molecular design can create different downstream development requirements.
• For a biosimilar project, connect manufacturing and analysis with the US commercialization sessions to consider technical comparability and the business case together.
• Use the one-to-one networking format to bring a discovery question to both an analytical supplier and a manufacturing partner, so the conversation follows the molecule through its next stages.